Annion Pharma Consulting DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Stealth’s Flight Path Returns to FDA for Rejected Barth Drug

22 Aug 2025

// BIOSPACE

J&J Boosts US Manufacturing Commitment by $2B Amid Tariff Threats

22 Aug 2025

// BIOSPACE

Krystal Halts Melanoma Study Following FDA's Replimune Rejection

22 Aug 2025

// FIERCE BIOTECH

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

EPSC

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

1 Corporate Content #SupplierSpotlight

media
1 Corporate Content #SupplierSpotlight

SERVICES

Sales, Marketing, Registration

pharmaServices
Sales, Marketing, Registration

Annion Pharma provides portfolio management for APIs & FDFs, competitive & market intelligence with regulatory toxicology support.

About

Annion Pharma aids clients in developing portfolios by considering internal strategies, financial goals, resources, and manufacturing capabilities, to bolster their business's competitive position. Our Puzzle Strategy involves consolidating information from diverse sources to furnish the most thorough market overview for your business. Annion provides long-term collaboration agreements prioritizing proactive engagement, problem-solving skills, high-quality standards, adaptability, efficiency, and swift response times. Our range of services includes risk assessment, toxicological reports, and substance categorizations.